Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ilad Alavi Darazam and Masoud Mardani.
Ilad Alavi Darazam
Connection Strength
0.595
Masoud Mardani
  1. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol. 2021 Oct; 99:107969.
    View in: PubMed
    Score: 0.239
  2. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107916.
    View in: PubMed
    Score: 0.238
  3. Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19. Pulm Pharmacol Ther. 2021 10; 70:102069.
    View in: PubMed
    Score: 0.060
  4. Anxiety among front-line health-care workers supporting patients with COVID-19: A global survey. Gen Hosp Psychiatry. 2021 Jan-Feb; 68:90-96.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.